Vaxcyte, Inc. (PCVX)
Health Care ยท Biological Products, (No Diagnostic Substances)
Vaxcyte, Inc. (PCVX) is listed on Nasdaq, where its shares have traded since June 12, 2020. SentiSense covers Vaxcyte, Inc. in the Health Care sector, and its Standard Industrial Classification is Biological Products, (No Diagnostic Substances). Grant Pickering is its chief executive officer. The company reports 507 employees, and its corporate website is www.vaxcyte.com.
About Vaxcyte, Inc.
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.
Latest reported results
Vaxcyte Inc. reported revenue of $0.00 for Q3 FY2026.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 321 institutions reported holding PCVX, with 167.0 million shares worth $9.7 billion in aggregate. The largest reported holders were FMR, Janus Henderson (Jupiter Topco) and T. Rowe Price. Of the 5 largest reported holders, all 5 added shares during the quarter.
More on PCVX
- PCVX sentiment: whether news and social coverage of Vaxcyte, Inc. leans bullish or bearish, and the stories driving it.
- PCVX ownership: all 321 reporting institutions, plus insider and congressional trades.
- PCVX financials: revenue, net income, operating margin and free cash flow through Q3 FY2026.
SentiSense also tracks daily options readings for Vaxcyte, Inc.: IV rank, put/call percentile, 25-delta skew and open-interest walls.
Frequently asked questions
What does Vaxcyte, Inc. do?
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases.
What sector is PCVX in?
SentiSense classifies Vaxcyte, Inc. in the Health Care sector, and its Standard Industrial Classification is Biological Products, (No Diagnostic Substances).
Where does PCVX stock trade?
Vaxcyte, Inc. (PCVX) is listed on Nasdaq, where its shares have traded since June 12, 2020.
Who is the CEO of Vaxcyte, Inc.?
Grant Pickering is the chief executive officer of Vaxcyte, Inc..